Veterinary Rapid Test Market Summary
According to Market Research Future analysis, the Veterinary Rapid Test Market size was valued at USD 2.58 Billion in 2024 & the market is projected to grow from USD 2.714 Billion in 2025 to USD 4.506 Billion by 2035, exhibiting a CAGR of 5.2% during the forecast period 2025-2035. North America led the market with over 44.57% share, generating around USD 1.15 billion in revenue.
Rising prevalence of zoonotic diseases and increasing pet ownership are key growth drivers for the Veterinary Rapid Test Market. Growing demand for quick, accurate diagnostics and point-of-care testing solutions is enhancing early disease detection and improving veterinary healthcare outcomes globally.
According to the World Health Organization, over 60% of emerging infectious diseases are zoonotic, while the Centers for Disease Control and Prevention states 75% of new infectious diseases originate in animals, supporting strong demand for rapid veterinary diagnostic solutions and early detection technologies globally.
Key Market Trends & Highlights
The Veterinary Rapid Test Market is experiencing robust growth driven by technological advancements and increasing demand for point-of-care testing.
- North America leads with 44.57% share in 2024, driven by advanced veterinary infrastructure and high pet healthcare expenditure.
- ELISA tests dominate with 58% share, driven by reliability and broad pathogen detection capabilities in veterinary diagnostics.
- Lateral flow tests grow rapidly with 42% share, supported by rising demand for point-of-care and rapid diagnostics.
Market Size & Forecast
| 2024 Market Size | 2.58 (USD Billion) |
| 2035 Market Size | 4.506 (USD Billion) |
| CAGR (2025 - 2035) | 5.2% |
Major Players
Companies such as IDEXX Laboratories (US), Zoetis (US), Thermo Fisher Scientific (US), Heska Corporation (US), Neogen Corporation (US), Virbac (FR), Randox Laboratories (GB), Boehringer Ingelheim (DE), Fujifilm (JP) are some of the major participants in the global market.